The Current Status and Prospects of the Application of Digital Technology in the Field of Pharmacovigilance of Rare Diseases

Objective To summarize the current status in the application of digital and intelligent technologies in the field of pharmacovigilance and to provide reference to the selection and development of methods for pharmacovigilance of rare diseases. Methods Searched five major databases-CNKI, WANFANG, VIP...

Full description

Saved in:
Bibliographic Details
Main Authors: CAO Ying, LIU Xinru, WANG Shengfeng, ZHUO Lin
Format: Article
Language:zho
Published: Editorial Office of Journal of Rare Diseases 2025-01-01
Series:罕见病研究
Subjects:
Online Access:https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2025.01.004
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849322150488440832
author CAO Ying
LIU Xinru
WANG Shengfeng
ZHUO Lin
author_facet CAO Ying
LIU Xinru
WANG Shengfeng
ZHUO Lin
author_sort CAO Ying
collection DOAJ
description Objective To summarize the current status in the application of digital and intelligent technologies in the field of pharmacovigilance and to provide reference to the selection and development of methods for pharmacovigilance of rare diseases. Methods Searched five major databases-CNKI, WANFANG, VIP, PubMed, and Embase, selected and the data of application of digital technology in the field of drug vigilance for rare diseases, extracted relevant information and conducted a systematic review. Results The application of digital technology in drug surveillance has not yet been used in the special field of rare diseases. Relevant case studies are insufficient. Two major challenges need to be addressed. One is the insufficient data sources and the other is technical limitations. Conclusions Based on the characteristics of drugs for rare diseases, this paper identifies data sources and intelligent technologies suitable for the field of drug vigilance for rare disease, proposes direction for potential development in the future, and makes targeted suggestions.
format Article
id doaj-art-59ed2299ea8f4ec1978016fc2bc6c20a
institution Kabale University
issn 2097-0501
language zho
publishDate 2025-01-01
publisher Editorial Office of Journal of Rare Diseases
record_format Article
series 罕见病研究
spelling doaj-art-59ed2299ea8f4ec1978016fc2bc6c20a2025-08-20T03:49:31ZzhoEditorial Office of Journal of Rare Diseases罕见病研究2097-05012025-01-0141222910.12376/j.issn.2097-0501.2025.01.004The Current Status and Prospects of the Application of Digital Technology in the Field of Pharmacovigilance of Rare DiseasesCAO Ying0LIU Xinru1WANG ShengfengZHUO LinSchool of Public Health, Peking University, Beijing 100191, ChinaSchool of Public Health, Peking University, Beijing 100191, ChinaObjective To summarize the current status in the application of digital and intelligent technologies in the field of pharmacovigilance and to provide reference to the selection and development of methods for pharmacovigilance of rare diseases. Methods Searched five major databases-CNKI, WANFANG, VIP, PubMed, and Embase, selected and the data of application of digital technology in the field of drug vigilance for rare diseases, extracted relevant information and conducted a systematic review. Results The application of digital technology in drug surveillance has not yet been used in the special field of rare diseases. Relevant case studies are insufficient. Two major challenges need to be addressed. One is the insufficient data sources and the other is technical limitations. Conclusions Based on the characteristics of drugs for rare diseases, this paper identifies data sources and intelligent technologies suitable for the field of drug vigilance for rare disease, proposes direction for potential development in the future, and makes targeted suggestions.https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2025.01.004digital intelligence technologyrare diseasespharmacovigilancedata resource
spellingShingle CAO Ying
LIU Xinru
WANG Shengfeng
ZHUO Lin
The Current Status and Prospects of the Application of Digital Technology in the Field of Pharmacovigilance of Rare Diseases
罕见病研究
digital intelligence technology
rare diseases
pharmacovigilance
data resource
title The Current Status and Prospects of the Application of Digital Technology in the Field of Pharmacovigilance of Rare Diseases
title_full The Current Status and Prospects of the Application of Digital Technology in the Field of Pharmacovigilance of Rare Diseases
title_fullStr The Current Status and Prospects of the Application of Digital Technology in the Field of Pharmacovigilance of Rare Diseases
title_full_unstemmed The Current Status and Prospects of the Application of Digital Technology in the Field of Pharmacovigilance of Rare Diseases
title_short The Current Status and Prospects of the Application of Digital Technology in the Field of Pharmacovigilance of Rare Diseases
title_sort current status and prospects of the application of digital technology in the field of pharmacovigilance of rare diseases
topic digital intelligence technology
rare diseases
pharmacovigilance
data resource
url https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2025.01.004
work_keys_str_mv AT caoying thecurrentstatusandprospectsoftheapplicationofdigitaltechnologyinthefieldofpharmacovigilanceofrarediseases
AT liuxinru thecurrentstatusandprospectsoftheapplicationofdigitaltechnologyinthefieldofpharmacovigilanceofrarediseases
AT wangshengfeng thecurrentstatusandprospectsoftheapplicationofdigitaltechnologyinthefieldofpharmacovigilanceofrarediseases
AT zhuolin thecurrentstatusandprospectsoftheapplicationofdigitaltechnologyinthefieldofpharmacovigilanceofrarediseases
AT caoying currentstatusandprospectsoftheapplicationofdigitaltechnologyinthefieldofpharmacovigilanceofrarediseases
AT liuxinru currentstatusandprospectsoftheapplicationofdigitaltechnologyinthefieldofpharmacovigilanceofrarediseases
AT wangshengfeng currentstatusandprospectsoftheapplicationofdigitaltechnologyinthefieldofpharmacovigilanceofrarediseases
AT zhuolin currentstatusandprospectsoftheapplicationofdigitaltechnologyinthefieldofpharmacovigilanceofrarediseases